Phase: Phase IIType: TreatmentStatus: ClosedAge: 18 and overSponsor: Pharmaceutical / IndustryProtocol IDs: SNDX-275-0301, NCT00676663Phase: Phase IIType: Biomarker/Laboratory analysis, TreatmentStatus: ClosedAge: 18 and overSponsor: NCIProtocol IDs: NCI-2010-02024, MC084B, N01CM62209, N01CM62205, CDR0000670136, MAYO-MC084B, 8341, NCT01105377Phase: Phase IIType: Biomarker/Laboratory analysis, TreatmentStatus: ClosedAge: 18 and overSponsor: NCIProtocol IDs: NCI-2011-02542, 10-466-A, N01CM00071, UCCRC-IL-057, IL-057, 8597, NCT01234532Phase: Phase IType: Biomarker/Laboratory analysis, TreatmentStatus: ClosedAge: 18 and overSponsor: NCIProtocol IDs: NCI-2009-00071, J0443, CDR0000405841, U01CA070095, JHOC-J0443, NCI-6591, JHOC-04061109, 6591, NCT00101179Phase: Phase IType: Biomarker/Laboratory analysis, TreatmentStatus: ClosedAge: 18 and overSponsor: NCIProtocol IDs: NCI-2011-01435, I-165409, CDR0000675600, RPCI-I-165409, 8272, NCT01159301
